SCHEMBL5484833

SCHEMBL5484833

CCO[C@H](C)Cc1ccc(OCCn2c(C(F)(F)F)nc3ccccc32)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.49
PPARG P37231 3/20 0.48
PPARA Q07869 3/20 0.48
PPARD Q03181 1/20 0.48
MAPT P10636 5/20 0.48
TP53 P04637 3/20 0.48
HPGD P15428 1/20 0.47
LMNA P02545 2/20 0.47
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PDE6D O43924 1/20 0.45
MEN1 O00255 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
AR P10275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5488110 1.00 SMN1; SMN2 (0.49) SMN1; SMN2PPARGPPARAPPARDMAPT
SCHEMBL5015518 0.88 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL5017679 0.88 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL5015073 0.88 PPARG (0.67) PPARGPPARAPPARD
SCHEMBL14010682 0.86 PPARG (0.56) PPARGPPARAPPARDMAPT
SCHEMBL5015569 0.85 PPARA (0.55) PPARGPPARAPPARD
SCHEMBL5023587 0.82 PPARG (0.50) PPARGPPARAPPARD
SCHEMBL5015605 0.81 PPARG (0.65) PPARGPPARAPPARD
SCHEMBL5015070 0.78 PPARA (0.54) PPARGPPARAPPARD
SCHEMBL5014125 0.78 PPARG (0.58) PPARGPPARAPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1869004-A1 SUBSTITUTED CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES AND LIPID DISORDERS, THEIR PREPARATION AND USE SK Holdings Co., Ltd. (KR) 2007-12-26 EP disclosed
WO-2006104349-A1 SUBSTITUTED CARBOXYLIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETES AND LIPID DISORDERS, THEIR PREPARATION AND USE SK HOLDINGS CO., LTD. (KR) 2006-10-05 WO disclosed